RIPK3 and cancer: On the one hand, the downregulation of the expression of numerous key molecules in necroptosis such as RIPK1, RIPK3, and MLKL has been found in different types of cancer cells, suggesting that cancer cells may evade necroptosis to survive (8, 9, 22, 23).